Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
J Pharmacol Exp Ther ; 340(2): 473-82, 2012 Feb.
Article in English | MEDLINE | ID: mdl-22106101

ABSTRACT

D prostanoid receptor 2 (DP2) [also known as chemoattractant receptor-homologous molecule expressed on T helper 2 (Th2) cells (CRTH2)] is selectively expressed by Th2 lymphocytes, eosinophils, and basophils and mediates recruitment and activation of these cell types in response to prostaglandin D2 (PGD2). (5-Fluoro-2-methyl-3-quinolin-2-ylmethylindo-1-yl)-acetic acid (OC000459) is an indole-acetic acid derivative that potently displaces [³H]PGD2 from human recombinant DP2 (K(i) = 0.013 µM), rat recombinant DP2 (K(i) = 0.003 µM), and human native DP2 (Th2 cell membranes; K(i) = 0.004 µM) but does not interfere with the ligand binding properties or functional activities of other prostanoid receptors (prostaglandin E1₋4 receptors, D prostanoid receptor 1, thromboxane receptor, prostacyclin receptor, and prostaglandin F receptor). OC000459 inhibited chemotaxis (IC50 = 0.028 µM) of human Th2 lymphocytes and cytokine production (IC50 = 0.019 µM) by human Th2 lymphocytes. OC000459 competitively antagonized eosinophil shape change responses induced by PGD2 in both isolated human leukocytes (pK(B) = 7.9) and human whole blood (pK(B) = 7.5) but did not inhibit responses to eotaxin, 5-oxo-eicosatetraenoic acid, or complement component C5a. OC000459 also inhibited the activation of Th2 cells and eosinophils in response to supernatants from IgE/anti-IgE-activated human mast cells. OC000459 had no significant inhibitory activity on a battery of 69 receptors and 19 enzymes including cyclooxygenase 1 (COX1) and COX2. OC000459 was found to be orally bioavailable in rats and effective in inhibiting blood eosinophilia induced by 13,14-dihydro-15-keto-PGD2 (DK-PGD2) in this species (ED50 = 0.04 mg/kg p.o.) and airway eosinophilia in response to an aerosol of DK-PGD2 in guinea pigs (ED50 = 0.01 mg/kg p.o.). These data indicate that OC000459 is a potent, selective, and orally active DP2 antagonist that retains activity in human whole blood and inhibits mast cell-dependent activation of both human Th2 lymphocytes and eosinophils.


Subject(s)
Eosinophils/drug effects , Indoleacetic Acids/pharmacology , Lymphocyte Activation/drug effects , Mast Cells/immunology , Prostaglandin Antagonists/pharmacology , Quinolines/pharmacology , Receptors, Immunologic/metabolism , Receptors, Prostaglandin/metabolism , Th2 Cells/drug effects , Animals , Apoptosis/drug effects , Arachidonic Acids/pharmacology , Binding, Competitive , CHO Cells , Calcium Signaling/drug effects , Cell Membrane/metabolism , Cell Shape/drug effects , Cell Shape/immunology , Chemokine CCL11/pharmacology , Chemotaxis/drug effects , Chemotaxis/immunology , Complement C5a/pharmacology , Cricetinae , Culture Media, Conditioned/pharmacology , Eosinophilia/chemically induced , Eosinophilia/prevention & control , Eosinophils/cytology , Eosinophils/immunology , Guinea Pigs , Humans , Indoleacetic Acids/pharmacokinetics , Indoleacetic Acids/therapeutic use , Interleukin-13/metabolism , Interleukin-5/pharmacology , Leukotriene B4/pharmacology , Lymphocyte Activation/immunology , Mast Cells/metabolism , Prostaglandin Antagonists/pharmacokinetics , Prostaglandin Antagonists/therapeutic use , Prostaglandin D2/analogs & derivatives , Prostaglandin D2/metabolism , Prostaglandin D2/pharmacology , Pulmonary Eosinophilia/chemically induced , Pulmonary Eosinophilia/prevention & control , Quinolines/pharmacokinetics , Quinolines/therapeutic use , Radioligand Assay , Rats , Rats, Sprague-Dawley , Receptors, Immunologic/genetics , Receptors, Prostaglandin/genetics , Recombinant Proteins/metabolism , Th2 Cells/cytology , Th2 Cells/immunology , Th2 Cells/metabolism , Transfection
SELECTION OF CITATIONS
SEARCH DETAIL
...